Neurodegenerative Diseases

Dementia Alzheimer's Disease Parkinson's Disease Cognitive Impairment Clinical Trials Therapeutics Multiple Sclerosis Diagnosis Optic Nerve Disorders Neuroprotection Amyotrophic Lateral Sclerosis Pathophysiology Alzheimer's Research Research Drug Development

5 ARTICLES

last wk.

Ambroxol Trial Confirms Safety, Brain Delivery and Early Cognitive Benefits in Parkinson’s Dementia

Phase 2 results showing stable biomarkers with improved cognition in genetically at-risk patients pave the way for a larger cognition-focused study later this year.

3 ARTICLES

last wk.

Dr Khan Flags Mid-Life Hearing Loss as Largest Preventable Dementia Risk

3 ARTICLES

last mo.

FDA Approves First Eye Implant to Preserve Vision in Rare Macular Telangiectasia

9 ARTICLES

last mo.

Alzheimer’s Drug Trials Surge 11% in 2025 as NICE Reviews Lecanemab and Donanemab

4 ARTICLES

2mo ago

Nanotherapy Using Sugar-Coated Fibers Shows Promise in Combating Alzheimer’s and ALS

5 ARTICLES

2mo ago

New Research Reveals Axons Have 'Pearls on a String' Structure

Neurodegenerative Diseases

Ambroxol Trial Confirms Safety, Brain Delivery and Early Cognitive Benefits in Parkinson’s Dementia

Dr Khan Flags Mid-Life Hearing Loss as Largest Preventable Dementia Risk

FDA Approves First Eye Implant to Preserve Vision in Rare Macular Telangiectasia

Alzheimer’s Drug Trials Surge 11% in 2025 as NICE Reviews Lecanemab and Donanemab

Nanotherapy Using Sugar-Coated Fibers Shows Promise in Combating Alzheimer’s and ALS

WEHI Scientists Unveil Small Molecule That Prevents Neuron Death

Clinical Trial Begins for Vitamin Therapy Targeting Glaucoma Progression

Study Finds No Evidence of Mystery Brain Disease in New Brunswick

EU Commission Approves First Alzheimer’s Therapy Targeting Disease Progression

Blood Test Advances Alzheimer’s Diagnosis and Staging with 92% Accuracy

New Research Reveals Axons Have 'Pearls on a String' Structure